These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3144595)

  • 21. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
    Marek GJ; Li AA; Seiden LS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agonist and antagonist activities of arylpiperazines at human platelet serotonin2 receptors.
    Britt SG; Gonias SL; Sanders JM; Vandenberg SR
    J Pharmacol Exp Ther; 1988 Dec; 247(3):965-70. PubMed ID: 3204525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of dopamine receptors explains the lack of 5-HT stereotypy on treatment with the putative 5-HT1A agonist LY165163.
    Donohoe TP; Hutson PH; Curzon G
    Psychopharmacology (Berl); 1987; 93(1):82-6. PubMed ID: 2957721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The behavioural effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants.
    Green AR; Guy AP; Gardner CR
    Neuropharmacology; 1984 Jun; 23(6):655-61. PubMed ID: 6462374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity.
    McCall RB; Patel BN; Harris LT
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1152-9. PubMed ID: 2958619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
    Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
    J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action.
    Gommans J; Hijzen TH; Maes RA; Olivier B
    Psychopharmacology (Berl); 1998 Jun; 137(3):292-302. PubMed ID: 9683007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further studies of serotonergic activity in the regulation of the cold stimulated thyrotropin secretion in male rats.
    Männistö PT; Tuominen RK
    Pharmacol Toxicol; 1988 Aug; 63(2):65-9. PubMed ID: 3186622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of TFMPP stimulus properties as a model of 5-HT1B receptor activation.
    Schechter MD
    Pharmacol Biochem Behav; 1988 Sep; 31(1):53-7. PubMed ID: 3252260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.
    McKearney JW
    Pharmacol Biochem Behav; 1990 Jan; 35(1):181-5. PubMed ID: 2315357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-(1-Naphthyl)piperazine, a central serotonin agonist.
    Fuller RW; Mason NR; Snoddy HD; Perry KW
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):37-45. PubMed ID: 2419952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.
    Rajkumar R; Pandey DK; Mahesh R; Radha R
    Eur J Pharmacol; 2009 Apr; 608(1-3):32-41. PubMed ID: 19269287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia.
    Kennett GA; Curzon G
    Br J Pharmacol; 1991 Aug; 103(4):2016-20. PubMed ID: 1912990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the contractile serotonergic receptor in guinea pig trachea with agonists and antagonists.
    Watts SW; Cohen ML
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1101-6. PubMed ID: 1312158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?
    Meneses A
    Cell Mol Neurobiol; 2002 Dec; 22(5-6):675-88. PubMed ID: 12585687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety.
    Wallis CJ; Lal H
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Apr; 22(3):547-65. PubMed ID: 9612850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible serotonergic and dopaminergic mediation of the N-ethyl-3,4-methylenedioxyamphetamine discriminative stimulus.
    Boja JW; Schechter MD
    Eur J Pharmacol; 1991 Sep; 202(3):347-53. PubMed ID: 1684158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical and behavioural evidence for an agonist action of 1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine (LY 165163) at central 5-HT receptors.
    Hutson PH; Donohoe TP; Curzon G
    Eur J Pharmacol; 1987 Jun; 138(2):215-23. PubMed ID: 3113985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.